Distribution and Clinical Utility of the 21-gene Recurrence Score in Pure Mucinous Breast Cancer Patients: a case-control study

The 21-gene recurrence score (RS) is increasingly being used for patients with early stage, hormone receptor-positive, Her-2-negative breast cancer. However, these results are largely from populations with infiltrating ductal carcinoma (IDC). The clinical value of RS testing in mucinous carcinoma ha...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Cancer
Main Authors: Wang, Wei, Chen, Xiaosong, Lin, Lin, Fei, Xiaochun, Garfield, David H., Hong, Jin, Gao, Weiqi, Zhu, Siji, Wu, Jiayi, Huang, Ou, He, Jianrong, Li, Yafen, Zhu, Li, Chen, Weiguo, Shen, Kunwei
Formato: Artigo
Idioma:Inglês
Publicado: Ivyspring International Publisher 2018
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6160674/
https://ncbi.nlm.nih.gov/pubmed/30271480
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.27291
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares